Jun 08, 2023 / 03:00PM GMT
Brandon Couillard - Jefferies - Analyst
All right. Good morning, everybody. Thanks for being here. Welcome to the Jefferies 2023 Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm. Very happy to have CareDx with us back in conference of this year and joining us for this conversation, CEO, Reg Seeto; CFO, Abhishek Jain; as well as SVP of R&D on the end, Rob Woodward. So, thank you guys for being here.
Reg Seeto - CareDx, Inc. - President & CEO
Thanks, again, Brandon.
Questions and Answers:
Brandon Couillard - Jefferies - AnalystAnd maybe just to kick it up briefly, Reg or Rob, for those that may be less familiar with what exactly has transpired recently, just recap to level-set, what transpired as far as the new MolDX billing decision and what it said and what the implications are?
Rob Woodward - CareDx, Inc. - SVP, Research & Development
Sure. So, in early March, MolDX came out with